Phreesia, Inc. (NYSE:PHR) SVP Sells $14,840.00 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 500 shares of Phreesia stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $29.68, for a total transaction of $14,840.00. Following the completion of the transaction, the senior vice president now directly owns 230,771 shares in the company, valued at $6,849,283.28. This represents a 0.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

David Linetsky also recently made the following trade(s):

• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total value of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The shares were sold at an average price of $24.85, for a total transaction of $294,547.05.

Phreesia Price Performance

Shares of NYSE PHR opened at $28.47 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The company’s fifty day moving average price is $24.98 and its 200 day moving average price is $23.28. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.90.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the prior year, the company posted ($0.58) EPS. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. Equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. KeyCorp increased their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Truist Financial lifted their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia has an average rating of “Buy” and a consensus price target of $31.15.

Institutional Trading of Phreesia

Several institutional investors have recently bought and sold shares of the business. Champlain Investment Partners LLC grew its stake in Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the period. Franklin Resources Inc. lifted its holdings in Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. State Street Corp grew its position in shares of Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Geode Capital Management LLC increased its stake in shares of Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Finally, TimesSquare Capital Management LLC raised its position in shares of Phreesia by 2.3% during the 3rd quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.